Tianma Gouteng Decoction for Essential Hypertension: Protocol for a Systematic Review and Meta-analysis

Overview

Journal Medicine (Baltimore)

Specialty General Medicine

Date 2018 Feb 22

PMID 29465596

Citations 5

Authors

Benjian Chen

Yuanping Wang

Zhuogen He

Dawei Wang

Xia Yan

Pingchang Xie

Affiliations

Soon will be listed here.

Abstract

Background: Essential hypertension is one of the most common chronic diseases, as well as one of the leading risk factors for cardio-cerebrovascular diseases. Tianma Gouteng decoction has been commonly used in clinical practice for patients with essential hypertension. It is important to update the search and evaluation to provide the best available evidence for essential hypertension. Here, we provide a protocol to evaluate the efficacy and safety of Tianma Gouteng decoction (TGD) for essential hypertension.

Methods: Retrieve literature on the TGD treatment for essential hypertension in the databases including PubMed, Cochrane Library, EMBASE, Chinese Biomedical database (CBM), Chinese National Knowledge Infrastructure (CNKI), Wanfang database, and Chinese Science and Technology Periodical database (VIP) on computer. The literature to be collected will be those published from the time when the respective databases were established to January 2018. The therapeutic effects according to the blood pressure (BP) will be accepted as the primary outcomes. We will use RevMan V.5.3 software as well to compute the data synthesis carefully when a meta-analysis is allowed.

Results: This study will provide a high-quality synthesis of current evidence of TGD for essential hypertension from several aspects including BP, life quality, heart rate, and adverse events.

Conclusion: The conclusion of our systematic review will provide evidence to judge whether TGD is an effective intervention for patient with essential hypertension.

Prospero Registration Number: PROSPERO CRD 42018082319.

Citing Articles

Network pharmacology implicates traditional Chinese medicine in regulating systemic homeostasis to benefit Alzheimer's disease.

Tsai S, Huang H Tzu Chi Med J. 2023; 35(2):120-130.

PMID: 37261294 PMC: 10227678. DOI: 10.4103/tcmj.tcmj_125_22.

Comparative transcriptomic analysis revealed novel potential therapeutic targets of traditional Chinese medicine (Pinggan-Qianyang decoction) on vascular remodeling in spontaneously hypertensive rats.

Yao J, Zhang C, Yang Y, Fang X, Chen Q, Zhong G Chin Med. 2021; 16(1):21.

PMID: 33568194 PMC: 7877093. DOI: 10.1186/s13020-021-00431-4.

The Potentials of Uncariae Ramulus Cum Uncis for the Treatment of Migraine: Targeting CGRP in the Trigeminovascular System.

Chong C, Zhong Z, Vong C, Wang S, Lu J, Zhong H Curr Neuropharmacol. 2020; 19(7):1090-1100.

PMID: 33121411 PMC: 8686315. DOI: 10.2174/1570159X18666201029150937.

The Effect of Chinese Herbal Medicine Combined With Western Medicine on Vascular Endothelial Function in Patients With Hypertension: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Ren W, Wang M, Liao J, Li L, Yang D, Yao R Front Pharmacol. 2020; 11:823.

PMID: 32612527 PMC: 7308496. DOI: 10.3389/fphar.2020.00823.

Randomized Controlled Trials of Tianma Gouteng Decoction Combined with Nifedipine in the Treatment of Primary Hypertension: A Systematic Review and Meta-Analysis.

Tai J, Zou J, Zhang X, Wang Y, Liang Y, Guo D Evid Based Complement Alternat Med. 2020; 2020:5759083.

PMID: 32089726 PMC: 7029275. DOI: 10.1155/2020/5759083.

References

Geleijnse J, Kok F, Grobbee D . Blood pressure response to changes in sodium and potassium intake: a metaregression analysis of randomised trials. J Hum Hypertens. 2003; 17(7):471-80. DOI: 10.1038/sj.jhh.1001575. View

Yang P, Shih W, Chu Y, Chen P, Wu C . Frequency and co-prescription pattern of Chinese herbal products for hypertension in Taiwan: a Cohort study. BMC Complement Altern Med. 2015; 15:163. PMC: 4457084. DOI: 10.1186/s12906-015-0690-8. View

Mancia G, Zanchetti A, Bohm M, Christiaens T, Cifkova R, De Backer G . 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2013; 34(28):2159-219. DOI: 10.1093/eurheartj/eht151. View

Kalish L, Buczynski B, Connell P, Gemmel A, Goertz C, Macklin E . Stop Hypertension with the Acupuncture Research Program (SHARP): clinical trial design and screening results. Control Clin Trials. 2004; 25(1):76-103. DOI: 10.1016/j.cct.2003.08.006. View

Hajjar I, Kotchen T . Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. JAMA. 2003; 290(2):199-206. DOI: 10.1001/jama.290.2.199. View

Zhang X, Sun T, Liu Z, Wang F, Wang Y, Liu J . Effects of Tianmagouteng particles on brain cognitive function in spontaneously hypertensive rats with hyperactivity of liver-yang: A [F-18] FDG micro-PET imaging study. Biomed Pharmacother. 2017; 95:1838-1843. DOI: 10.1016/j.biopha.2017.08.100. View

Wang J, Xiong X . Control strategy on hypertension in chinese medicine. Evid Based Complement Alternat Med. 2011; 2012:284847. PMC: 3239016. DOI: 10.1155/2012/284847. View

Zhang Y, Moran A . Trends in the Prevalence, Awareness, Treatment, and Control of Hypertension Among Young Adults in the United States, 1999 to 2014. Hypertension. 2017; 70(4):736-742. PMC: 5657525. DOI: 10.1161/HYPERTENSIONAHA.117.09801. View

Barnes P, Bloom B, Nahin R . Complementary and alternative medicine use among adults and children: United States, 2007. Natl Health Stat Report. 2009; (12):1-23. View

10.

Macklin E, Wayne P, Kalish L, Valaskatgis P, Thompson J, Pian-Smith M . Stop Hypertension with the Acupuncture Research Program (SHARP): results of a randomized, controlled clinical trial. Hypertension. 2006; 48(5):838-45. DOI: 10.1161/01.HYP.0000241090.28070.4c. View

11.

Carey R, Whelton P . Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Synopsis of the 2017 American College of Cardiology/American Heart Association Hypertension Guideline. Ann Intern Med. 2018; 168(5):351-358. DOI: 10.7326/M17-3203. View

12.

Singh R, Suh I, Singh V, Chaithiraphan S, Laothavorn P, Sy R . Hypertension and stroke in Asia: prevalence, control and strategies in developing countries for prevention. J Hum Hypertens. 2000; 14(10-11):749-63. DOI: 10.1038/sj.jhh.1001057. View

13.

Bishop F, Yardley L, Lewith G . Why consumers maintain complementary and alternative medicine use: a qualitative study. J Altern Complement Med. 2010; 16(2):175-82. DOI: 10.1089/acm.2009.0292. View

14.

Haspula D, Clark M . Neuroinflammation and sympathetic overactivity: Mechanisms and implications in hypertension. Auton Neurosci. 2018; 210:10-17. DOI: 10.1016/j.autneu.2018.01.002. View

15.

Wang J, Feng B, Yang X, Liu W, Liu Y, Zhang Y . Tianma gouteng yin as adjunctive treatment for essential hypertension: a systematic review of randomized controlled trials. Evid Based Complement Alternat Med. 2013; 2013:706125. PMC: 3655574. DOI: 10.1155/2013/706125. View